Ali J. Satvat Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ali J. Satvat.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali J. Satvat. Ali J. Satvat is Director in Coherus BioSciences, Inc. ($CHRS) and Director in Eidos Therapeutics, Inc. ($EIDX) and Director in BridgeBio Pharma, Inc. ($BBIO).
Latest Insider Trading Transactions of Ali J. Satvat
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BBIO, CHRS, EIDX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 10.99 | 79,702 | 875,925 | 79,702 | |
| Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 16.68 | 39,851 | 664,715 | 39,851 | |
| Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 26.21 | 39,851 | 1,044,495 | 39,851 | |
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 20.34 | 43,056 | 875,759 | 0 | |
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 30.87 | 21,528 | 664,569 | 0 | |
| Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 48.51 | 21,528 | 1,044,323 | 0 | |
| Jun 04 2020 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 | |
| May 29 2020 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | A | 48.51 | 21,528 | 1,044,323 | 21,528 | |
| Jan 14 2020 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
| Dec 16 2019 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 37.45 | 82,878 | 3,103,781 | 82,878 | |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| Jun 13 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
| May 29 2019 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | P | 25.93 | 1,103,848 | 28,622,779 | 23,693,148 | 22.6 M to 23.7 M (+4.89 %) |
| Jan 30 2019 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
| Jul 03 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | A | 20.34 | 43,056 | 875,759 | 43,056 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | C | 0.00 | 12,832,123 | 0 | 0 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | C | 0.00 | 2,909,029 | 0 | 0 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | X | 0.00 | 332,262 | 0 | 2,909,029 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | X | 10.83 | 332,262 | 3,599,992 | 0 | |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | P | 17.00 | 1,000,000 | 17,000,000 | 19,614,655 | 18.6 M to 19.6 M (+5.37 %) |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Payment of Exercise | F | 17.00 | 211,762 | 3,599,954 | 18,614,655 | 18.8 M to 18.6 M (-1.12 %) |
| Jun 22 2018 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Buy | C | 0.00 | 18,826,417 | 0 | 18,826,417 | 0 to 18.8 M |
| Feb 05 2018 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
| May 19 2017 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 23.80 | 20,000 | 476,000 | 20,000 | |
| May 26 2016 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 18.28 | 10,000 | 182,800 | 10,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Nov 10 2014 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 13.50 | 14,997 | 202,460 | 14,997 |
Page: 1